BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 24293567)

  • 1. Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis.
    Sansonno D; Russi S; Serviddio G; Conteduca V; D'Andrea G; Sansonno L; Pavone F; Lauletta G; Mariggiò MA; Dammacco F
    J Rheumatol; 2014 Jan; 41(1):91-8. PubMed ID: 24293567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genotype CC of IL-28B SNP rs12979860 is significantly associated with a sustained virological response in chronic HCV-infected Pakistani patients.
    Khubaib B; Saleem S; Idrees M; Afzal S; Wasim M
    J Dig Dis; 2015 May; 16(5):293-8. PubMed ID: 25708904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment.
    Boglione L; Cusato J; Allegra S; Cariti G; Di Perri G; D'Avolio A
    Arch Virol; 2015 Aug; 160(8):2009-17. PubMed ID: 26060059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-nucleotide polymorphisms of IL-10 and IL-28B as predictors of the response of IFN therapy in HCV genotype 4-infected children.
    Shaker OG; Nassar YH; Nour ZA; El Raziky M
    J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):155-60. PubMed ID: 23880623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.
    Shaker OG; Sadik NA
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1842-9. PubMed ID: 23020144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus and Interleukin-28B polymorphism in the prediction of response to interferon therapy in hepatitis C patients.
    Zekri AR; Abdullah D; Osman A; El-Rouby MN; Zayed N; Esmat G; Elakel W; Hafez HA
    Arab J Gastroenterol; 2015; 16(3-4):84-9. PubMed ID: 26526510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.
    Bitetto D; Fattovich G; Fabris C; Ceriani E; Falleti E; Fornasiere E; Pasino M; Ieluzzi D; Cussigh A; Cmet S; Pirisi M; Toniutto P
    Hepatology; 2011 Apr; 53(4):1118-26. PubMed ID: 21480318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the genetic variation in interleukin 28B and response to antiviral therapy in patients with chronic hepatitis C.
    Xie JQ; Guo XY; Zhang XH; Lin BL; Xie DY; Gao ZL; Wang GS; Zhao ZX
    Chin Med J (Engl); 2012 Jul; 125(13):2334-8. PubMed ID: 22882858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PROGNOSTIC VALUE OF THE COMBINATION OF BLOOD GROUP SPECIFICITY AND INTERLEUKIN 28B GENE POLYMORPHISM FOR ESTIMATION OF EFFICIENCY OF THERAPY WITH THE USE OF PEGYLATED INTERFERON α-2 AND RIBAVARIN IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C].
    Ogurtsov PP; Kukhareva EI
    Klin Med (Mosk); 2016; 94(3):224-30. PubMed ID: 27522730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin.
    Huang CF; Yeh ML; Hsieh MH; Hsieh MY; Lin ZY; Chen SC; Wang LY; Huang JF; Juo SH; Lin YC; Dai CY; Chuang WL; Yu ML
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1515-20. PubMed ID: 23560893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.
    Bitetto D; De Feo T; Mantovani M; Falleti E; Fabris C; Belli LS; Fagiuoli S; Burra P; Piccolo G; Donato MF; Toniutto P; ; Cmet S; Cussigh A; Viganò R; Airoldi A; Pasulo L; Colpanij M; De Martin E; Gambato M; Rigamonti C
    Dig Liver Dis; 2013 Nov; 45(11):927-32. PubMed ID: 23722013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The difference of IL-28B polymorphisms between hepatitis C patients with and without cryoglobulinemia].
    Fan XH; Wu CH; Zheng YY; Wang LF; Huo N; Shao CP; Lu HY; Xu XY; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):429-33. PubMed ID: 24034843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of IL-28: rs12979860 and rs8099917 Polymorphisms in a Cohort of Cuban Chronic HCV Genotype 1b Patients.
    Palenzuela Gardón D; Guillen IA; Fernández JR; Camacho H; Estevez ZC; Dueñas S; Alvares-Lajonchere L; Amador Y; Martinez-Donato G; Han J; Zhang Z; Zhang X; Gao Y; Campaña JR; Novoa LI
    J Biomol Tech; 2017 Jul; 28(2):80-86. PubMed ID: 28058039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
    Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
    Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential response to pegylated interferon plus ribavirin combination therapy in chronic hepatitis C and HIV/HCV co-infected patients].
    Liu B; Cai WP; Hu FY; Xu M; Lan Y; Tang XP
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):829-33. PubMed ID: 24331692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study.
    Hu CC; Lin CL; Chang LC; Chien CH; Chen LW; Liu CJ; Chien RN
    BMC Infect Dis; 2015 Mar; 15():156. PubMed ID: 25888020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C.
    Nadia K; Hicham E; Reda TM; Nadia T; Elarbi B; Saâd E; Mimoun Z; Saâd M
    Gene; 2015 Aug; 568(1):31-4. PubMed ID: 25958342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of Taiwan.
    Cheng CH; Lin CC; Chen HL; Lin IT; Wu CH; Lee YK; Wong MW; Bair MJ
    Kaohsiung J Med Sci; 2017 Oct; 33(10):510-515. PubMed ID: 28962822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment.
    Fateh A; Aghasadeghi MR; Keyvani H; Mollaie HR; Yari S; Hadizade Tasbiti AR; Ghazanfari M; Monavari SH
    Asian Pac J Cancer Prev; 2015; 16(5):1873-80. PubMed ID: 25773839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.